General MedicationsTRANSDERMALGeneric
NICOTROL
NICOTINE
Standard Dose
15MG/16HR
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NICOTROL is listed in Drugs@FDA under application 020536 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient NICOTINE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 15MG/16HR Sponsor MCNEIL CONS Submission history Latest submission status date: 2002-07-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview NICOTROL is listed in Drugs@FDA under application 020536 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NICOTINE Form and strength FILM, EXTENDED RELEASE;TRANSDERMAL - 15MG/16HR Sponsor MCNEIL CONS Submission history Latest submission status date: 2002-07-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.